TW200608996A - Novel solid dispersion and manufacturing method thereof - Google Patents
Novel solid dispersion and manufacturing method thereofInfo
- Publication number
- TW200608996A TW200608996A TW094123116A TW94123116A TW200608996A TW 200608996 A TW200608996 A TW 200608996A TW 094123116 A TW094123116 A TW 094123116A TW 94123116 A TW94123116 A TW 94123116A TW 200608996 A TW200608996 A TW 200608996A
- Authority
- TW
- Taiwan
- Prior art keywords
- solid dispersion
- manufacturing
- novel solid
- drug
- present
- Prior art date
Links
- 239000007962 solid dispersion Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004203799A JP2007223903A (ja) | 2004-07-09 | 2004-07-09 | 新規な固体分散体およびその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200608996A true TW200608996A (en) | 2006-03-16 |
Family
ID=34979219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094123116A TW200608996A (en) | 2004-07-09 | 2005-07-08 | Novel solid dispersion and manufacturing method thereof |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2007223903A (zh) |
| TW (1) | TW200608996A (zh) |
| WO (1) | WO2006006691A2 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| EP2540317A4 (en) * | 2010-02-22 | 2014-04-16 | Daiichi Sankyo Co Ltd | SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION |
| WO2011102504A1 (ja) | 2010-02-22 | 2011-08-25 | 第一三共株式会社 | 経口用徐放性固形製剤 |
| US10231929B2 (en) | 2014-03-18 | 2019-03-19 | Takeda Pharmaceutical Company Limited | Solid dispersion |
| WO2020261619A1 (ja) * | 2019-06-26 | 2020-12-30 | 株式会社リコー | 医薬組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01010675A (es) * | 1999-04-23 | 2002-06-04 | Takeda Chemical Industries Ltd | Compuestos de 5-piridil-1, 3-azol, proceso para su produccion y uso de los mismos. |
| KR100381834B1 (ko) * | 2000-05-20 | 2003-04-26 | 이상득 | 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법 |
| DE60319073T2 (de) * | 2002-03-20 | 2009-02-05 | Elan Pharma International Ltd. | Nanopartikelzusammensetzungen von mitogen-aktivierten protein (map) kinase inhibitoren |
-
2004
- 2004-07-09 JP JP2004203799A patent/JP2007223903A/ja not_active Withdrawn
-
2005
- 2005-07-08 WO PCT/JP2005/013099 patent/WO2006006691A2/en not_active Ceased
- 2005-07-08 TW TW094123116A patent/TW200608996A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006006691A3 (en) | 2006-03-30 |
| JP2007223903A (ja) | 2007-09-06 |
| WO2006006691A2 (en) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004100857A3 (en) | Highly plastic granules for making fast melting tablets | |
| WO2008007152A3 (en) | Preparation of pharmaceutical formulations | |
| UA93353C2 (ru) | Производство фармацевтических композиций c быстрым высвобождением ha ochobe водонерастворимых лекарсвенных средств и фармацевтические композиции, полученные способом согласно изобретению | |
| WO2006125620A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
| MY147393A (en) | Administration of dipeptidyl peptidase inhibitors | |
| ATE226066T1 (de) | Verfahren zur stabilisierung von polyvinylpyrrolidon-zubereitungen | |
| MXPA05011596A (es) | Derivados de amino-propanol como modulador de receptor de esfingosina-1-fosfato. | |
| ATE361977T1 (de) | In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen | |
| NZ527585A (en) | Tablets quickly disintegrated in oral cavity | |
| PL372250A1 (en) | Pharmaceutical tablet | |
| GEP20115231B (en) | 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones | |
| ATE482194T1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| UA90708C2 (ru) | Таблетки с улучшенной дисперсностью лекарственного вещества | |
| TW200608996A (en) | Novel solid dispersion and manufacturing method thereof | |
| MY141743A (en) | 3h-quinazolin-4-one derivatives | |
| PT1753712E (pt) | Derivados de amino-propanol | |
| DE69901062D1 (de) | Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung | |
| MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
| ATE322891T1 (de) | Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel | |
| TW200621307A (en) | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion | |
| UA95253C2 (ru) | Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит | |
| WO2008057704A3 (en) | A jewelry item with a novel setting for precious stones | |
| WO2004018010A3 (en) | Methods of drug delivery using sulphated chitinous polymers | |
| WO2005013935A3 (en) | Composition for releasing a weak base for an extended period of time | |
| BG108686A (en) | Cytisine-containing medicamentous form |